Cargando…
Force of infection: a determinant of vaccine efficacy?
Vaccine efficacy (VE) can vary in different settings. Of the many proposed setting-dependent determinants of VE, force of infection (FoI) stands out as one of the most direct, proximate, and actionable. As highlighted by the COVID-19 pandemic, modifying FoI through non-pharmaceutical interventions (...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042006/ https://www.ncbi.nlm.nih.gov/pubmed/33846340 http://dx.doi.org/10.1038/s41541-021-00316-5 |
_version_ | 1783678042006093824 |
---|---|
author | Kaslow, David C. |
author_facet | Kaslow, David C. |
author_sort | Kaslow, David C. |
collection | PubMed |
description | Vaccine efficacy (VE) can vary in different settings. Of the many proposed setting-dependent determinants of VE, force of infection (FoI) stands out as one of the most direct, proximate, and actionable. As highlighted by the COVID-19 pandemic, modifying FoI through non-pharmaceutical interventions (NPIs) use can significantly contribute to controlling transmission and reducing disease incidence and severity absent highly effective pharmaceutical interventions, such as vaccines. Given that NPIs reduce the FoI, the question arises as to if and to what degree FoI, and by extension NPIs, can modify VE, and more practically, as vaccines become available for a pathogen, whether and which NPIs should continue to be used in conjunction with vaccines to optimize controlling transmission and reducing disease incidence and severity. |
format | Online Article Text |
id | pubmed-8042006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80420062021-04-28 Force of infection: a determinant of vaccine efficacy? Kaslow, David C. NPJ Vaccines Perspective Vaccine efficacy (VE) can vary in different settings. Of the many proposed setting-dependent determinants of VE, force of infection (FoI) stands out as one of the most direct, proximate, and actionable. As highlighted by the COVID-19 pandemic, modifying FoI through non-pharmaceutical interventions (NPIs) use can significantly contribute to controlling transmission and reducing disease incidence and severity absent highly effective pharmaceutical interventions, such as vaccines. Given that NPIs reduce the FoI, the question arises as to if and to what degree FoI, and by extension NPIs, can modify VE, and more practically, as vaccines become available for a pathogen, whether and which NPIs should continue to be used in conjunction with vaccines to optimize controlling transmission and reducing disease incidence and severity. Nature Publishing Group UK 2021-04-12 /pmc/articles/PMC8042006/ /pubmed/33846340 http://dx.doi.org/10.1038/s41541-021-00316-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Perspective Kaslow, David C. Force of infection: a determinant of vaccine efficacy? |
title | Force of infection: a determinant of vaccine efficacy? |
title_full | Force of infection: a determinant of vaccine efficacy? |
title_fullStr | Force of infection: a determinant of vaccine efficacy? |
title_full_unstemmed | Force of infection: a determinant of vaccine efficacy? |
title_short | Force of infection: a determinant of vaccine efficacy? |
title_sort | force of infection: a determinant of vaccine efficacy? |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042006/ https://www.ncbi.nlm.nih.gov/pubmed/33846340 http://dx.doi.org/10.1038/s41541-021-00316-5 |
work_keys_str_mv | AT kaslowdavidc forceofinfectionadeterminantofvaccineefficacy |